Apis Capital's flagship fund, which surged 55% in 2025, spotlights clinical-stage biotech Celcuity in its latest investor letter, citing the company's novel platform for matching cancer patients with targeted therapies.
After a period of Bitcoin dominance, a confluence of technological maturity, shifting institutional narratives, and regulatory clarity could propel Ethereum back into the spotlight. Analysts point to its foundational role in decentralized finance and a series of upcoming catalysts as reasons for a potential breakout year.
Despite a 14% share price decline over the past quarter, Associated British Foods (LON:ABF) demonstrates robust underlying financial health, driven by strong earnings growth and efficient capital reinvestment, suggesting potential for a market correction.
While savings accounts offer safety and liquidity, experts warn that historically low interest rates are silently eroding purchasing power. We examine the risks of idle cash and explore strategies to protect—and grow—your nest egg.
GIGABYTE is expanding its strategic partnership with AMD to launch a new generation of AI-enhanced gaming laptops, motherboards, and monitors. This collaboration integrates AMD's Ryzen AI and 3D V-Cache technologies directly into consumer hardware, aiming to deliver tangible benefits in gaming smoothness, system stability, and creative workflow acceleration.
ServiceNow accelerates its push into real-world AI automation, expanding key partnerships and retooling its global partner ecosystem to embed AI agents directly into enterprise workflows, as the company seeks to translate AI investment into tangible business value under investor pressure.
A sharp correction in Bitcoin prices has left corporate giant MicroStrategy nursing over $1 billion in unrealized losses and triggered massive outflows from spot ETFs. Despite the sell-off, CEO Michael Saylor signals unwavering commitment, framing the downturn as a strategic buying opportunity.
The cryptocurrency market extended its losses on Monday, with the global market cap falling 2.9% to $2.65 trillion. Major assets like Bitcoin and Ethereum led the decline, while significant outflows from U.S. spot ETFs and shifting macroeconomic expectations fueled a wave of 'extreme fear' among investors.
Recent data shows the average Bitcoin held by U.S. spot ETFs is now worth less than its purchase price, following two consecutive weeks of major outflows that have deepened the cryptocurrency's downturn.
Amid a patchy eurozone recovery, investors are scanning the market's fringes for potential. We spotlight three small-cap stocks from Norway and Sweden, each navigating unique challenges while showing flashes of promise for the discerning, risk-tolerant investor.
Amidst a cautiously recovering Eurozone economy, we spotlight three lesser-known European companies—spanning finance, telecom, and food production—that combine strong fundamentals with compelling growth narratives for discerning investors.
As global investment in artificial intelligence infrastructure accelerates, a handful of semiconductor giants stand to reap outsized rewards. We examine the foundational players whose technology is enabling this historic build-out.
President Trump's anticipated nomination of former Fed Governor Kevin Warsh, a vocal critic of the central bank's post-crisis asset purchases, is shifting market focus from interest rates to the future of the Fed's $6.6 trillion balance sheet and its fundamental role in financial markets.
As Diebold Nixdorf accelerates its AI-driven self-checkout initiatives, highlighted by a new study on the Australian retail market, investors are weighing whether this technological pivot can solidify its ongoing operational turnaround and justify its current valuation.
The Northern Ireland Executive has suspended a planned revaluation of hotel business rates, averting significant tax increases for accommodation providers slated for 2026 and providing temporary stability for the region's tourism industry.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
Gold and silver extended their historic sell-off on Monday, with spot prices tumbling as much as 4% in early trading. The dramatic reversal follows a record-breaking rally that had lifted precious metals to unprecedented heights, stunning veteran traders and analysts alike.
Greenlight Capital has spotlighted Core Natural Resources (CNR), the entity formed from the merger of Arch Resources and CONSOL Energy, as a key coal investment. The fund cites the company's valuation and combined asset base, even as the sector grapples with operational challenges. This endorsement brings renewed scrutiny to CNR's integration path and its strategy in a complex market.
After a bruising year that saw its shares tumble by a third, biotech giant CSL is back in the spotlight. We delve beyond the headline numbers, examining valuation models and market sentiment to assess if the sell-off has created a compelling entry point for long-term investors.
As earnings season unfolds, Apple and Meta Platforms both posted impressive results, but their paths diverge sharply. Apple's growth reaccelerates on iPhone strength, while Meta's robust outlook is shadowed by soaring AI investments. The debate over which stock offers the better value is heating up.
